06996.HK
Antengene Corporation Limited
HKSE · Healthcare · Biotechnology · CN
HKD 3.56
−0.70%Margins
Gross margin
89.6%
EBITDA margin
-14.7%
EBIT margin
-20.0%
Net margin
-27.7%
FCF margin
-27.8%
-19.5%
Return on equity
-11.7%
Return on assets
-11.0%
Return on invested capital
0.46x
Asset turnover
-HKD 148.6M
Cash from operations
HKD 1.42
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026